-
1 Comment
Tianjin Lisheng Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 9.1% below its 200 day moving average.
From a valuation standpoint, the stock is 72.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.7.
Tianjin Lisheng Pharmaceutical Co.,Ltd's total revenue sank by 44.5% to $225M since the same quarter in the previous year.
Its net income has dropped by 232.2% to $-71M since the same quarter in the previous year.
Finally, its free cash flow fell by 3500.2% to $-65M since the same quarter in the previous year.
Based on the above factors, Tianjin Lisheng Pharmaceutical Co.,Ltd gets an overall score of 1/5.
| Industry | Drug Manufacturers - Specialty & Generic |
|---|---|
| Exchange | SHE |
| CurrencyCode | CNY |
| Sector | Healthcare |
| ISIN | CNE100000NJ9 |
| Market Cap | 6B |
|---|---|
| PE Ratio | 14.15 |
| Beta | 0.13 |
| Target Price | None |
| Dividend Yield | 3.9% |
Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers pharmaceutical, traditional Chinese medicine, and antibiotic products in various forms, such as oral solid dosage forms, soft capsules, sterile preparations, and raw materials primarily for cardiovascular and digestive system applications. Its products also include Shoubishan capsules, Jiayindapamide tablets, Sanyu Zhengtong tablets, Xifuni cefdinir dispersible tablets, and Youhao Maren soft capsules. In addition, the company provides pharmaceutical manufacturing outsourcing services and technology research and development services. Further, it exports its products. The company was founded in 1951 and is headquartered in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Jinhao Pharmaceutical Co., Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002393.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026